发明名称 |
Substituted indazole derivatives active as kinase inhibitors |
摘要 |
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer. |
申请公布号 |
US9029356(B2) |
申请公布日期 |
2015.05.12 |
申请号 |
US201414212256 |
申请日期 |
2014.03.14 |
申请人 |
Nerviano Medical Sciences S.R.L. |
发明人 |
Lombardi Borgia Andrea;Menichincheri Maria;Orsini Paolo;Panzeri Achille;Perrone Ettore;Vanotti Ermes;Nesi Marcella;Marchionni Chiara |
分类号 |
A61K31/4162;A61K31/497;A61K31/415;A61K31/55;A61K31/445;A61K31/535;C07D231/56;C07D401/12;C07D401/14;C07D403/14;C07D405/04;C07D405/14;C07D405/12 |
主分类号 |
A61K31/4162 |
代理机构 |
Scully, Scott, Murphy & Presser, P.C. |
代理人 |
Scully, Scott, Murphy & Presser, P.C. |
主权项 |
1. A compound of formula (Ia), wherein: R is aryl substituted with one or more halogen; R1, R2 and R3 are hydrogen; Ar is aryl substituted with one or more NR5R6; and R5 and R6 are independently selected from hydrogen and optionally substituted heterocyclyl, or R5 and R6, taken together with the nitrogen atom to which they are bonded, form an optionally substituted heterocyclyl group; or a pharmaceutically acceptable salt thereof. |
地址 |
Nerviano (MI) IT |